REQUEST A DEMO
Total
USD $0.00
Search more companies

Medeq 2222 OOD (Медея 2222 ООД) (Bulgaria)

Main Activities: Pharmacies and Drug Stores
Full name: Medeq 2222 OOD Profile Updated: September 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Medeq 2222 OOD (Медея 2222 ООД) is a company based in Bulgaria, with its head office in Svishtov. It operates in the Pharmacies and Drug Stores industry. Medeq 2222 OOD (Медея 2222 ООД) was incorporated on September 11, 2026. It currently has a total number of 44 (2024) employees. The company’s latest financial report indicates a net sales revenue increase of 15.28% in 2024. There was a total growth of 25.66% in Medeq 2222 OOD (Медея 2222 ООД)’s total assets over the same period. Medeq 2222 OOD (Медея 2222 ООД)’s net profit margin decreased by 1.49% in 2024.

Headquarters
Dimitar Shishmanov 4
Svishtov; Veliko Tarnovo; Postal Code: 5250

Contact Details: Purchase the Medeq 2222 OOD (Медея 2222 ООД) report to view the information.

Basic Information
Total Employees:
Purchase the Medeq 2222 OOD (Медея 2222 ООД) report to view the information.
Registered Capital:
Purchase the Medeq 2222 OOD (Медея 2222 ООД) report to view the information.
Financial Auditors:
Purchase the Medeq 2222 OOD (Медея 2222 ООД) report to view the information.
Incorporation Date:
September 11, 2026
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Medeq 2222 OOD (Медея 2222 ООД) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
15.28%
Total Operating Revenue
15.45%
Operating Profit
-94.73%
Net Profit/Loss for the Period
-15.14%
Total Assets
25.66%
Total Equity
27.3%
Operating Profit Margin
-95.53%
Net Profit Margin
-1.49%
Return on Equity (ROE)
-10.81%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?